Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDP733 in Female Patients With IBS-c
NCT00547469Phase 3Unknown
- Sponsor
- Dynogen Pharmaceuticals, Inc.
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of pumosetrag in irritable bowel syndrome (IBS), sponsored by Dynogen Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
pumosetrag
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00547469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547469.